A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including


Journal

African journal of thoracic and critical care medicine
ISSN: 2617-0205
Titre abrégé: Afr J Thorac Crit Care Med
Pays: South Africa
ID NLM: 101751995

Informations de publication

Date de publication:
2021
Historique:
accepted: 05 10 2021
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 5 11 2021
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is transmitted mainly by aerosol in particles <10 µm that can remain suspended for hours before being inhaled. Because particulate filtering facepiece respirators ('respirators'; e.g. N95 masks) are more effective than surgical masks against bio-aerosols, many international organisations now recommend that health workers (HWs) wear a respirator when caring for individuals who may have COVID-19. In South Africa (SA), however, surgical masks are still recommended for the routine care of individuals with possible or confirmed COVID-19, with respirators reserved for so-called aerosol-generating procedures. In contrast, SA guidelines do recommend respirators for routine care of individuals with possible or confirmed tuberculosis (TB), which is also transmitted via aerosol. In health facilities in SA, distinguishing between TB and COVID-19 is challenging without examination and investigation, both of which may expose HWs to potentially infectious individuals. Symptom-based triage has limited utility in defining risk. Indeed, significant proportions of individuals with COVID-19 and/or pulmonary TB may not have symptoms and/or test negative. The prevalence of undiagnosed respiratory disease is therefore likely significant in many general clinical areas (e.g. waiting areas). Moreover, a proportion of HWs are HIV-positive and are at increased risk of severe COVID-19 and death. Sustained improvements in infection prevention and control (IPC) require reorganisation of systems to prioritise HW and patient safety. While this will take time, it is unacceptable to leave HWs exposed until such changes are made. We propose that the SA health system adopts a target of 'zero harm', aiming to eliminate transmission of respiratory pathogens to all individuals in every healthcare setting. Accordingly, we recommend: the use of respirators by all staff (clinical and non-clinical) during activities that involve contact or sharing air in indoor spaces with individuals who: (

Identifiants

pubmed: 34734176
doi: 10.7196/AJTCCM.2021.v27i4.173
pmc: PMC8545268
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Medical Research Council
ID : MR/V028782/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : UM1 AI154463
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of interest: Dr Martinson’s institution receives grants from Pfizer for research into pneumonia. All other authors have no conflict of interest to declare.

Références

Int J Tuberc Lung Dis. 2007 Jun;11(6):593-605
pubmed: 17519089
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
J Hosp Infect. 2021 Apr;110:89-96
pubmed: 33453351
Sci Rep. 2019 Feb 20;9(1):2348
pubmed: 30787335
N Engl J Med. 1995 Jan 12;332(2):92-8
pubmed: 7990907
Open Forum Infect Dis. 2017 Aug 29;4(3):ofx137
pubmed: 28875155
PLoS One. 2015 Sep 18;10(9):e0138149
pubmed: 26383102
J Hosp Infect. 2020 Jul;105(3):569-570
pubmed: 32405126
J Occup Environ Hyg. 2017 Nov;14(11):898-906
pubmed: 28650715
Clin Microbiol Infect. 2021 Apr;27(4):511-519
pubmed: 33484843
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Nat Commun. 2021 Mar 12;12(1):1653
pubmed: 33712573
Semin Respir Crit Care Med. 2016 Dec;37(6):855-867
pubmed: 27960209
Emerg Infect Dis. 2011 Mar;17(3):488-94
pubmed: 21392441
Sci Rep. 2021 Jun 3;11(1):11778
pubmed: 34083700
JAMA. 2020 Jul 7;324(1):94-96
pubmed: 32496504
Int J Nurs Stud Adv. 2021 Nov;3:100032
pubmed: 34079957
J Occup Environ Hyg. 2018 Aug;15(8):588-597
pubmed: 29750600
Semin Respir Crit Care Med. 2020 Aug;41(4):592-604
pubmed: 32564347
Int J Tuberc Lung Dis. 2018 Mar 1;22(3):264-272
pubmed: 29471903
J Hosp Infect. 2019 Oct;103(2):175-184
pubmed: 31279762
Hum Resour Health. 2020 Oct 31;18(1):83
pubmed: 33129313
Healthcare (Basel). 2020 Jul 23;8(3):
pubmed: 32717841
Lancet. 2021 May 1;397(10285):1603-1605
pubmed: 33865497
Am Rev Respir Dis. 1967 Mar;95(3):435-42
pubmed: 6018703
BMC Biomed Eng. 2021 Jun 7;3(1):10
pubmed: 34099062
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1576-1583
pubmed: 33119554
Lancet. 2021 Sep 18;398(10305):1037-1038
pubmed: 34391505
Infect Dis Poverty. 2020 May 25;9(1):56
pubmed: 32450916
Clin Infect Dis. 2021 Jan 23;72(1):27-29
pubmed: 32502233
Anaesthesia. 2021 Mar;76 Suppl 3:16-18
pubmed: 33368170
Open Forum Infect Dis. 2017 Aug 07;4(3):ofx116
pubmed: 28852676
S Afr Med J. 2020 Dec 09;0(0):13162
pubmed: 33334390
Anesth Prog. 2020 Sep 1;67(3):127-134
pubmed: 32556161
J Infect Dis. 2017 Nov 3;216(suppl_6):S629-S635
pubmed: 29112747
Lancet Infect Dis. 2016 Feb;16(2):227-38
pubmed: 26867464
Int J Nurs Stud. 2020 Aug;108:103629
pubmed: 32512240
Environ Health Perspect. 2021 Apr;129(4):47002
pubmed: 33793301
Lancet HIV. 2021 May;8(5):e294-e305
pubmed: 33915101
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33571106
Sci Rep. 2020 Nov 11;10(1):19589
pubmed: 33177563
PLoS One. 2020 Jun 3;15(6):e0234025
pubmed: 32492045
Int J Occup Med Environ Health. 2004;17(1):9-16
pubmed: 15212202
PLoS One. 2020 Nov 3;15(11):e0241536
pubmed: 33141862
Eur Respir J. 2010 Jan;35(1):27-33
pubmed: 20044459
J Nurs Adm. 2015 Apr;45(4):183-4
pubmed: 25803796
J Intern Med. 2021 Nov;290(5):1010-1027
pubmed: 34105202
Int J Infect Dis. 2021 Jul;108:212-216
pubmed: 33901650
BMJ Qual Saf. 2020 Jan;29(1):60-63
pubmed: 31289111
J Formos Med Assoc. 2021 Jun;120(6):1293-1295
pubmed: 33246741
Am J Trop Med Hyg. 2011 Jan;84(1):30-7
pubmed: 21212197
J Clin Tuberc Other Mycobact Dis. 2019 Aug 21;17:100118
pubmed: 31788560
PLoS Med. 2006 Dec;3(12):e494
pubmed: 17194191
Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015
pubmed: 32860699
Nat Rev Microbiol. 2021 Aug;19(8):528-545
pubmed: 33753932
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Eur Respir J. 2011 Jul;38(1):139-46
pubmed: 21148230
Am J Infect Control. 2012 May;40(4):375-80
pubmed: 21864945
ERJ Open Res. 2020 Mar 16;6(1):
pubmed: 32201694
BMC Health Serv Res. 2016 Aug 20;16(1):416
pubmed: 27544429
PLoS Med. 2007 Jan;4(1):e20
pubmed: 17227135
N Engl J Med. 2021 Oct 14;385(16):1474-1484
pubmed: 34320281
Int J Environ Res Public Health. 2020 Jun 03;17(11):
pubmed: 32503223
BMC Public Health. 2021 May 20;21(1):953
pubmed: 34016067
Am J Respir Crit Care Med. 2013 May 1;187(9):960-6
pubmed: 23413265
Trop Med Int Health. 2010 Oct;15(10):1179-84
pubmed: 20831672
Antimicrob Resist Infect Control. 2020 Dec 18;9(1):202
pubmed: 33339522
BMJ Open. 2020 Oct 16;10(10):e040321
pubmed: 33067299
Eur Respir J. 2015 May;45(5):1364-73
pubmed: 25700382
Anaesthesia. 2021 Feb;76(2):174-181
pubmed: 33022093
Lancet Respir Med. 2020 Sep;8(9):914-924
pubmed: 32717211
Clin Infect Dis. 2021 Aug 2;73(3):e830-e841
pubmed: 32936877

Auteurs

K Dheda (K)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.

S Charalambous (S)

The Aurum Institute, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

A S Karat (AS)

TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.

A von Delft (A)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
TB Proof, South Africa.

U G Lalloo (UG)

Gateway Private Hospital Medical Centre, Umhlanga Ridge, South Africa.
Durban International Clinical Research Site, Durban, South Africa.

R van Zyl Smit (R)

Division of Pulmonology and Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

R Perumal (R)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.

B W Allwood (BW)

Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.

A Esmail (A)

Clinical Trials Unit, University of Cape Town Lung Institute, South Africa.

M L Wong (ML)

Division of Pulmonology, Department of Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

A G Duse (AG)

Clinical Microbiology & Infectious Diseases, School of Pathology of the NHLS & University of the Witwatersrand, Johannesburg, South Africa.

G Richards (G)

Department of Critical Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

C Feldman (C)

Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

M Mer (M)

Department of Medicine, Divisions of Pulmonology and Critical Care, Charlotte Maxeke Johannesburg Academic Hospital and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

K Nyamande (K)

Department of Pulmonology, Nelson R Mandela School of Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.

U Lalla (U)

Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.

C F N Koegelenberg (CFN)

Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.

F Venter (F)

Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

H Dawood (H)

Greys Hospital, Pietermaritzburg, South Africa.

S Adams (S)

Division of Occupational Medicine, School of Public Health and Family Medicine, University of Cape Town, South Africa.

N A B Ntusi (NAB)

Division of Cardiology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

H-M van der Westhuizen (HM)

TB Proof, South Africa.
Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom.

M-Y S Moosa (MS)

Department of Infectious Diseases, Division of Internal Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Southern African HIV Clinicians Society.

N A Martinson (NA)

Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.
Johns Hopkins University Center for TB Research, Baltimore, MD, USA.

H Moultrie (H)

National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
Clinical Microbiology & Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

J Nel (J)

Division of Infectious Diseases, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa.

H Hausler (H)

TB HIV Care, Cape Town, South Africa.

W Preiser (W)

Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa.

L Lasersohn (L)

South African Society of Anaesthesiologists.
Department of Anaesthesia, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Division of Critical Care, Chris Hani Baragwanath Hospital and University of the Witwatersrand, Johannesburg, South Africa.

H J Zar (HJ)

Department of Paediatrics & Child Health, Red Cross Children's Hospital and SAMRC Unit on Child and Adolescent Health, University of Cape Town, South Africa.

G J Churchyard (GJ)

The Aurum Institute, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.

Classifications MeSH